AKT1 and asthma: Moreover, inhibition of PI3K/Akt/mTOR and TLR4/MyD88/NF-κB signaling with targeted molecules can attenuate pathological mechanisms of asthma and play an important role in protecting airways against allergic response and inflammation pathology (63).